This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Ahotupa M, Ruutu M, Mantyla E. Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins. Clin Biochem 29, 139–144, 1996.Search in Google Scholar
Ahotupa M, Marniemi J, Lehtimaki T, Talvinen K, Raitakari OT, Vasankari T, Viikari J, Luoma J, Yla-Herttuala S, Baseline diene conjugation in LDL lipids as a direct measure of in vivo LDL oxidation. Clin Biochem 31, 257–261, 1998.Search in Google Scholar
Alharbi KK, Khan IA, Syed R. Association of apolipoprotein E polymorphism with T2D mellitus in a Saudi population. DNA Cell Biol 33, 637–641, 2014.Search in Google Scholar
Anthopoulos PG, Hamodrakas SJ, Bagos PG. Apolipoprotein E polymorphisms and T2D: a meta-analysis of 30 studies including 5423 cases and 8197 controls. Mol Genet Metab 100, 283–291, 2010.Search in Google Scholar
Asghar S, Asghar S, Shahid S, Fatima M, Bukhari SMH, Nadeem Siddiqui S. Metabolic syndrome in type 2 diabetes mellitus patients: prevalence, risk factors, and associated microvascular complications. Cureus 15, e39076, 2023.Search in Google Scholar
Boren J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ, Nordestgaard BG, Watts GF, Bruckert E, Fazio S, Ference BA, Graham I, Horton JD, Landmesser U, Laufs U, Masana L, Pasterkamp G, Raal FJ, Ray KK, Schunkert H, Taskinen MR, van de Sluis B, Wiklund O, Tokgozoglu L, Catapano AL, Ginsberg HN. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 41, 2313–2330, 2020.Search in Google Scholar
Chaaba R, Attia N, Hammami S, Smaoui M, Ben Hamda K, Mahjoub S, Hammami M. Association between apolipoprotein E polymorphism, lipids, and coronary artery disease in Tunisian T2D. J Clin Lipidol 2, 360–364, 2008.Search in Google Scholar
Chaudhary R, Likidlilid A, Peerapatdit T, Tresukosol D, Srisuma S, Ratanamaneechat S, Sriratanasathavorn C. Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of T2D and coronary artery disease. Cardiovasc Diabetol. 11, 36, 2012.Search in Google Scholar
Chen DW, Shi JK, Li Y, Yang Y, Ren SP. Association between ApoE polymorphism and T2D: A meta-analysis of 59 studies. Biomed Environ Sci 11, 823–838, 2019.Search in Google Scholar
Das M, Pal S, Ghosh A. Synergistic effects of ACE (I/D) and Apo E (Hha I) gene polymorphisms on obesity, fat mass, and blood glucose level among the adult Asian Indians: A population-based study from Calcutta, India. Indian J Endocrinol Metab 17, 101–104, 2013.Search in Google Scholar
Desai K, Mistry P, Bagget C, Burroughs AK, Bellamy MF, Owen JS. Inhibition of platelet aggregation by abnormal high density lipoprotein particles in plasma from patients with hepatic cirrhosis. Lancet 1, 693–695, 1989.Search in Google Scholar
Dore GA, Elias MF, Robbins MA, Elias PK, Nagy Z. Presence of the APOE epsilon4 allele modifies the relationship between T2D and cognitive performance: The Maine-Syracuse Study. Diabetologia 52, 2551–2560, 2009.Search in Google Scholar
El-Lebedy D, Raslan HM, Mohammed AM. Apolipoprotein E gene polymorphism and risk of T2D and cardiovascular disease. Cardiovasc Diabetol 15, 12, 2016.Search in Google Scholar
Eto M, Saito M, Okada M, Kume Y, Kawasaki F, Matsuda M, Yoneda M, Matsuki M, Takigami S, Kaku K. Apolipo-protein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients. Am J Kidney Dis 40, 243–251, 2002.Search in Google Scholar
Fan P, Liu H, Wang Y, Zhang F, Bai H. Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS. Reprod Biomed Online 24, 197–205, 2012.Search in Google Scholar
Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H, Watts GF, Boren J, Fazio S, Horton JD, Masana L, Nicholls SJ, Nordestgaard BG, van de Sluis B, Taskinen MR, Tokgozoglu L, Landmesser U, Laufs U, Wiklund O, Stock JK, Chapman MJ, Catapano AL. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 38, 2459–2472, 2017.Search in Google Scholar
Galal AA, Abd Elmajeed AA, Elbaz RA, Wafa AM, Elshazli RM. Association of Apolipoprotein E gene polymorphism with the risk of T2DM and obesity among Egyptian subjects. Gene 769, 145223, 2021.Search in Google Scholar
Gonzalez-Aldaco K, Roman S, Torres-Reyes LA, Panduro A. Association of apolipoprotein e2 allele with insulin resistance and risk of T2D mellitus among an admixed population of Mexico. Diabetes Metab Syndr Obes 13, 3527–3534, 2020.Search in Google Scholar
Guangda X, Yuhua W. Apolipoprotein e4 allele and endothelium-dependent arterial dilation in T2D mellitus without angiopathy. Diabetologia 46, 514–519, 2003.Search in Google Scholar
Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31, 545–548, 1990.Search in Google Scholar
Kalina A, Szalai C, Prohaszka Z, Reiber I, Csaszar A. Association of plasma lipid levels with apolipoprotein E polymorphism in T2D. Diabetes Res Clin Pract 56, 63–68, 2002.Search in Google Scholar
Lange LA, Burdon K, Langefeld CD, Liu Y, Beck SR, Rich SS, Freedman BI, Brosnihan KB, Herrington DM, Wagenknecht LE, Bowden DW. Heritability and expression of C-reactive protein in T2D in the Diabetes Heart Study. Ann Hum Genet 70, 717–725, 2006.Search in Google Scholar
Leiva E, Mujica V, Orrego R, Prieto M, Arredondo M. Diabetes Apolipoprotein E polymorphism in type 2 diabetic patients of Talca, Chile. Res Clin Pract 68, 244–249, 2005.Search in Google Scholar
Lemieux S, Prud’homme D, Bouchard C, Tremblay A, Despres JP. A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue. Am J Clin Nutr 64, 685–693, 1996.Search in Google Scholar
Lugrin J, Rosenblatt-Velin N, Parapanov R, Liaudet L. The role of oxidative stress during inflammatory processes. Biol Chem 395, 203–230, 2014.Search in Google Scholar
Luo JQ, Ren H, Banh HL, Liu MZ, Xu P, Fang PF, Xiang DX. The associations between apolipoprotein E gene epsilon2/epsilon3/epsilon4 oolymorphisms and the risk of coronary artery disease in patients with T2D mellitus. Front Physiol 8, 1031, 2017.Search in Google Scholar
Maratni NPT, Saraswati MR, Dewi NNA, Yasa IWPS, Eka Widyadharma IP, Putra IBK, Suastika K.J Association of apolipoprotein E gene polymorphism with lipid profile and ischemic stroke risk in T2D mellitus patients. Nutr Metab 26, 5527736, 2021.Search in Google Scholar
Morbois-Trabut L, Chabrolle C, Garrigue MA, Lasfargues G, Lecomte P. Apolipoprotein E genotype and plasma lipid levels in Caucasian diabetic patients. Diabetes Metab 32, 270–275, 2006.Search in Google Scholar
Nishigaki I, Haghara M, Taunekawa H, Maseki M, Yagi K. Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med 25, 373–378, 1981.Search in Google Scholar
Ortega MA, Fraile-Martinez O, Naya I, Garcia-Honduvilla N, Alvarez-Mon M, Bujan J, Asunsolo A, de la Torre B. Type 2 diabetes mellitus associated with obesity (diabesity). The central role of gut microbiota and its translational applications. Nutrients 12, 2749, 2020.Search in Google Scholar
Parhofer KG. Interaction between glucose and lipid metabolism: more than diabetic dyslipidemia. Diabetes Metab J 39, 353–362, 2015.Search in Google Scholar
Pitchika A, Markus MRP, Schipf S, Teumer A, Van der Auwera S, Nauck M, Dorr M, Felix S, Jorgen Grabe H, Volzke H, Ittermann T. Longitudinal association of Apolipoprotein E polymorphism with lipid profile, T2D and metabolic syndrome: Results from a 15 year follow-up study. Diabetes Res Clin Pract 185, 109778, 2022.Search in Google Scholar
Reznik Y, Morello R, Pousse P, Mahoudeau J, Fradin S. The effect of age, body mass index, and fasting triglyceride level on postprandial lipemia is dependent on apolipoprotein E polymorphism in subjects with non-insulin-dependent diabetes mellitus. Metabolism 51, 1088–1092, 2002.Search in Google Scholar
Santos-Ferreira C, Baptista R, Oliveira-Santos M, Costa R, Pereira Moura J, Gonçalves LJ. Apolipoprotein E2 genotype is associated with a 2-fold increase in the incidence of T2D mellitus: results from a long-term observational study. J Lipids 2019,1698610, 2019.Search in Google Scholar
Schneider DJ. Factors contributing to increased platelet reactivity in people with diabetes. Diabetes Care 32, 525–527, 2009.Search in Google Scholar
Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol 9, 754, 2018.Search in Google Scholar
Tabatabaei-Malazy O, Fakhrzadeh H, Qorbani M, Amiri P, Larijani B, Tavakkoly-Bazzaz J, Amoli MM. Apolipoprotein E gene polymorphism and its effect on anthropometric measures in normoglycemic subjects and T2D. J Diabetes Metab Disord 11, 18, 2012.Search in Google Scholar
Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes 6, 456–480, 2015.Search in Google Scholar
Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature 269, 604–607, 1977.Search in Google Scholar
Van Gaal LF, Vansant GA, De Leeuw IH. Upper body adiposity and the risk for atherosclerosis. J Am Coll Nutr 8, 504–514, 1989.Search in Google Scholar
Vauhkonen I, Niskanen L, Ryynanen M, Voutilainen R, Partanen J, Toyry J, Mercuri M, Rauramaa R, Uusitupa M. Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects. Diabet Med 14, 748–756, 1997.Search in Google Scholar
Wang N, Liu Q, Liu H, Cong X, Yang H, Yu Y, Cao Y, Ma L. J Association of apolipoprotein E polymorphisms and risks of ischemic stroke in Chinese patients with type 2 diabetes mellitus. Diabetes Res 2021, 8816996, 2021.Search in Google Scholar
Wehr H, Bednarska-Makaruk M, Graban A, Kunicki PK, Lojkowska W, Rodo M, Ryglewicz D. Apolipoprotein E polymorphism and low density lipoprotein (LDL) oxidation in patients with dementia. Folia Neuropathol 41, 65–68, 2003.Search in Google Scholar
Zarkesh M, Daneshpour MS, Faam B, Hedayati M, Azizi F. Is there any association of apolipoprotein E gene polymorphism with obesity status and lipid profiles? Tehran Lipid and Glucose Study (TLGS). Gene 509, 282–285, 2012.Search in Google Scholar
Zeng Y, Wen S, Huan L, Xiong L, Zhong B, Wang P. Association of Apo E gene polymorphisms with serum lipid levels and the risk of T2D mellitus in the Chinese Han population of central China. PeerJ 11, e15226, 2023.Search in Google Scholar
